Powered by ZigaForm version

Application for Clinical Trials

Product Details

Title of Study: Primary Prevention of Stroke in Nigerian Children with Sickle Cell Disease in Sub Saharan Africa II: a partial double blind randomized Phase III clinical trial


Protocol; Version: ; May 23, 2016

Phase of Study: Phase 3;

Study Type: grant aided tudy

Approval Date:

Applicant Name: Aminu Kano Teaching Hospital

Address: Zaria road, Kano

Date of Application: 2016-09-20

Applicant Name: Aminu Kano Teaching Hospital

Sponsor: Vanderbilt University School of Medicine

Address of Sponsor: Nashville USA

Trial Sites: 1. Aminu Kano Teaching Hospital, Kano 2. Murtala Mohammed Specialist Hospital, Kano 3. Barau Dikko Teaching Hospital, Kaduna

Product Type: Drug

Status of Approval: On going

Was this post helpful?